ArticleFrontiers in immunology2026

Efficacy and safety of TACE combined with MWA followed by immune checkpoint inhibitors and anti-VEGF/tyrosine kinase inhibitors in hepatocellular carcinoma beyond the up-to-7.

Yang Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.